Early research (Phase 1)Study completedNCT00005967
What this trial is testing
Tipifarnib in Treating Patients With Advanced Hematologic Cancer
Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
National Cancer Institute (NCI) 36